8-K: Calumet Restates Q1, Q2 2025 Financials Due to Cash Flow Error

Calumet, Inc. announced that its unaudited interim financial statements for Q1 and Q2 2025 can no longer be relied upon due to a misclassification error in cash flow reporting.

Summary

• The Audit Committee of Calumet, Inc.'s Board of Directors concluded on November 3, 2025, that the unaudited interim consolidated financial statements for the periods ended March 31, 2025, and June 30, 2025 (Non-Reliance Periods), require restatement.
• An error was identified in the historical unaudited condensed consolidated statements of cash flows for the Non-Reliance Periods, causing misclassification of certain amounts between cash flows from operating activities and cash flows from financing activities.
• This error had no impact on revenue, net income (loss), or cash and cash equivalents.
• The misclassifications related to debt extinguishment costs from refinancing activities and one inventory financing arrangement.
• The error originated from a newly identified material weakness related to the preparation and review of the unaudited condensed consolidated statements of cash flows.
• For the three months ended March 31, 2025, previously reported net cash used in operating activities of $110.6 million is expected to be restated to $29.3 million, and net cash provided by financing activities of $190.3 million is expected to be restated to $109.0 million.
• For the six months ended June 30, 2025, previously reported net cash used in operating activities of $108.0 million is expected to be restated to $31.1 million, and net cash provided by financing activities of $188.5 million is expected to be restated to $111.6 million.
• Management re-evaluated disclosure controls and procedures, concluding they were ineffective as of March 31, 2025, and June 30, 2025, due to the material weakness.
• The company intends to restate its financial statements for the Non-Reliance Periods and file amended Quarterly Reports on Form 10-Q as soon as practicable.
• Investors should not rely on previously issued financial information for the Non-Reliance Periods until the restated statements are filed.

Sentiment

Score: 3

Explanation: The filing indicates a significant financial reporting issue with a material weakness in internal controls, leading to a restatement of prior period cash flow statements. While net income and overall cash balances are unaffected, the misclassification and control deficiencies are serious concerns for investors regarding the reliability of financial reporting and corporate governance.

Negatives

• Previously issued unaudited interim consolidated financial statements for Q1 and Q2 2025 can no longer be relied upon.
• A material weakness in internal control over financial reporting was identified, specifically related to the preparation and review of cash flow statements.
• Disclosure controls and procedures were deemed ineffective as of March 31, 2025, and June 30, 2025.
• The company is required to restate its financial statements for the Non-Reliance Periods.

Risks

• Material weakness in internal control over financial reporting, which could lead to further errors or misstatements.
• Potential for additional errors to be identified during further review and analysis of the Non-Reliance Periods.
• Erosion of investor confidence due to unreliable past financial statements and internal control deficiencies.
• Regulatory scrutiny and potential consequences related to ineffective internal controls and financial restatements.

Future Outlook

The company intends to restate its financial statements for the Non-Reliance Periods to correct the misclassification error and file amended Quarterly Reports on Form 10-Q as soon as practicable. Investors and others should rely on financial information and other disclosures regarding the Non-Reliance Periods only once the company restates its condensed consolidated unaudited financial statements.

Management Comments

• The company intends to restate its financial statements for the Non-Reliance Periods to correct the misclassification error discussed above and file amended Quarterly Reports on Form 10-Q as soon as practicable.

Industry Context

This type of financial restatement, particularly stemming from identified material weaknesses in internal controls, can erode investor confidence and is a common challenge for companies operating in complex financial reporting environments. It underscores the ongoing importance of robust internal controls and accurate financial disclosures, which are under constant scrutiny by regulators and the investment community.

Corporate Governance

Stakeholder Impact

• Shareholders: May experience reduced confidence due to unreliable past financial statements and identified internal control weaknesses.
• Investors: Advised not to rely on previously issued financial information for the Non-Reliance Periods until restated, impacting investment decisions and analysis.

Next Steps

• Restate financial statements for the Non-Reliance Periods.
• File amended Quarterly Reports on Form 10-Q as soon as practicable.

Key Dates

Recommendation

The company announced a restatement of its Q1 and Q2 2025 financial statements due to a material weakness in internal controls over financial reporting, specifically concerning cash flow classifications. While the error did not affect revenue, net income, or overall cash and cash equivalents, the identification of a material weakness and ineffective disclosure controls is a significant concern for investors regarding the reliability of financial reporting. The stock should be held until the restated financials are released and the company demonstrates remediation of the identified material weakness, allowing for a clearer assessment of the company's operational and financial health.

Keywords

Calumet, CLMT, SEC filing, 8-K, financial restatement, cash flow error, material weakness, internal controls, Q1 2025, Q2 2025, financial reporting, disclosure controls